Clinicopathological Characteristics and Clinical Course of Non-muscle-invasive Bladder Cancer Secondary to Radical Nephroureterectomy

Read full text Summarise with VIRAT
Authors: TAKUMA SATO, TAKESHI SANO, Hisanobu Adachi, Yoshihiro Ikeda, JUN TAKEMOTO, Shingo Myoen, Koji Mitsuzuka, Atsushi Kyan, Hiroshi Aoki, SATORU TOKUYAMA, HIDEO SAITO, SHINICHI YAMASHITA
+3 more YOICHI ARAI, TAKASHI KOBAYASHI, AKIHIRO ITO
Cited by: 0
References: 26

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Background/Aim: The clinical course and clinicopathological characteristics of primary non-muscle-invasive bladder cancer (NMIBC) have been well characterized; however, those of NMIBC secondary to radical nephroureterectomy (RNU) remain unclear. We aimed to compare these parameters between NMIBC following RNU and primary NMIBC. Patients and Methods: The records of patients who underwent transurethral resection of bladder tumor and were later diagnosed with NMIBC between January 2009 and December 2016 were retrospectively analyzed. Patients who underwent RNU for upper tract urinary carcinoma (UTUC) and subsequently developed NMIBC were included in the UTUC-NMIBC group. Patients who were newly diagnosed with NMIBC were included in the primary NMIBC group. The clinicopathological characteristics and recurrence-free survival rates in patients were compared between the groups using Pearson’s chi-squared test and the Kaplan–Meier method with the log-rank test, respectively. Further, the predictors of recurrence-free survival were identified using Cox proportional hazards regression analysis. Results: A total of 59 and 1,019 patients were included in the UTUC-NMIBC and primary NMIBC groups, respectively. Significant differences were observed between the groups in tumor stage, grade, largest tumor size, and presence of carcinoma in situ. Additionally, patients in the UTUC-NMIBC group exhibited significantly poorer recurrence-free survival than those in the primary NMIBC group (p=0.0035). Univariate and multivariate Cox regression analysis revealed differences in the predictors of recurrence-free survival between the patients in both groups. Conclusion: NMIBC secondary to RNU exhibits distinct tumor characteristics and recurrence-free survival compared with primary NMIBC. Further studies are needed to clarify the mechanisms underlying these differences.

Fields of Study & Subjects

Bladder and Urothelial Cancer Treatments Urinary and Genital Oncology Studies Multiple and Secondary Primary Cancers

Publication details

Journal / source
Anticancer Research
Volume
46
Issue
4
Pages
2077–2086
Publication date
27 March 2026
Language
EN